Furthermore, concurrent Dek overexpression and 4NQO exposure increased the incidence of gross esophageal tumors demonstrating for the first time that Dek overexpression contributes to ESCC tumor growth in vivo. This evidence concerns the gene DEK and esophageal squamous cell carcinoma.